Order Article Reprints

Wang Y, Xie H, Ma J, Du T, Gao S, Chen Y, Lin S-Y, Liang D. Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer. Pharmaceutics. 2025; 17(8):1052. https://doi.org/10.3390/pharmaceutics17081052

Wang, Yang, Huan Xie, Jing Ma, Ting Du, Song Gao, Yuan Chen, Shiaw-Yih Lin, and Dong Liang. 2025. "Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer" Pharmaceutics 17, no. 8: 1052. https://doi.org/10.3390/pharmaceutics17081052

Wang, Y., Xie, H., Ma, J., Du, T., Gao, S., Chen, Y., Lin, S.-Y., & Liang, D. (2025). Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer. Pharmaceutics, 17(8), 1052. https://doi.org/10.3390/pharmaceutics17081052